{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:28:02Z","timestamp":1778279282882,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.cvsm.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T09:32:21Z","timestamp":1363944741000},"page":"407-415","source":"Crossref","is-referenced-by-count":10,"title":["Oral Hypoglycemics in Cats with Diabetes Mellitus"],"prefix":"10.1016","volume":"43","author":[{"given":"Carrie A.","family":"Palm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward C.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2012.12.002_bib1","series-title":"Canine and feline endocrinology and reproduction","first-page":"339","article-title":"Diabetes mellitus","author":"Feldman","year":"2003"},{"issue":"3","key":"10.1016\/j.cvsm.2012.12.002_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/diabetes.52.3.581","article-title":"Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection","volume":"52","author":"Robertson","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.cvsm.2012.12.002_bib3","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0002-9440(10)64852-3","article-title":"A\u00a0feline model of experimentally induced islet amyloidosis","volume":"157","author":"Hoenig","year":"2000","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.cvsm.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11259-009-9314-4","article-title":"Effect of glimepiride and nateglinide on serum insulin and glucose concentration in healthy cats","volume":"33","author":"Mori","year":"2009","journal-title":"Vet Res Commun"},{"issue":"4","key":"10.1016\/j.cvsm.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2460\/ajvr.2005.66.581","article-title":"Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats","volume":"66","author":"Bennett","year":"2005","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2460\/javma.1993.203.06.0821","article-title":"Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats","volume":"203","author":"Nelson","year":"1993","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2012.12.002_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0b013e318235f1bb","article-title":"Evolving metformin treatment strategies in Type-2 diabetes: from immediate-release metformin monotherapy to extended-release combination therapy","author":"Chacra","year":"2012","journal-title":"Am J Ther"},{"issue":"6","key":"10.1016\/j.cvsm.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2460\/ajvr.1999.60.06.738","article-title":"Pharmacokinetics of the anti-hyperglycemic agent metformin in cats","volume":"60","author":"Michels","year":"1999","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1939-1676.2004.tb00130.x","article-title":"Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats","volume":"18","author":"Nelson","year":"2004","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2133\/dmpk.DMPK-10-RV-090","article-title":"Drug-induced idiosyncratic hepatotoxicity: prevention strategy after the troglitazone case","volume":"26","author":"Ikeda","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1016\/j.cvsm.2012.12.002_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2460\/ajvr.2000.61.775","article-title":"Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats","volume":"61","author":"Michels","year":"2000","journal-title":"Am J Vet Res"},{"issue":"11","key":"10.1016\/j.cvsm.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2460\/ajvr.2003.64.1409","article-title":"Effect of darglitazone on glucose clearance and lipid metabolism in obese cats","volume":"64","author":"Hoenig","year":"2003","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2012.12.002_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/dia.2006.8.677","article-title":"Clinical studies on chromium picolinate supplementation in diabetes mellitus: a review","volume":"8","author":"Broadhurst","year":"2006","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.cvsm.2012.12.002_bib14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.46.11.1786","article-title":"Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes","volume":"46","author":"Anderson","year":"1997","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.cvsm.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00075197-199811000-00005","article-title":"Chromium update: examining recent literature 1997-98","volume":"1","author":"Preuss","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"11","key":"10.1016\/j.cvsm.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2460\/ajvr.1999.60.11.1360","article-title":"Effects of chromium supplementation on glucose tolerance in obese and nonobese cats","volume":"60","author":"Cohn","year":"1999","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/jfms.2001.0157","article-title":"Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats","volume":"4","author":"Appleton","year":"2002","journal-title":"J\u00a0Feline Med Surg"},{"issue":"1","key":"10.1016\/j.cvsm.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2337\/diabetes.50.1.131","article-title":"Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats","volume":"50","author":"Mu\u00f1oz","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.cvsm.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/BTER:88:2:097","article-title":"Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects","volume":"88","author":"Domingo","year":"2002","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"10.1016\/j.cvsm.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0165-6147(00)89043-4","article-title":"The role of vanadium in the management of diabetes","volume":"16","author":"Brichard","year":"1995","journal-title":"Trends Pharmacol Sci"},{"issue":"1\u20132","key":"10.1016\/j.cvsm.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF01075941","article-title":"In\u00a0vivo and in\u00a0vitro studies of vanadate in human and rodent diabetes mellitus","volume":"153","author":"Goldfine","year":"1995","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.cvsm.2012.12.002_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1096-2867(97)80018-7","article-title":"Oral hypoglycemic agents for noninsulin-dependent diabetes mellitus in the cat","volume":"12","author":"Greco","year":"1997","journal-title":"Semin Vet Med Surg (Small Anim)"},{"issue":"1","key":"10.1016\/j.cvsm.2012.12.002_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jfms.2000.0057","article-title":"Current understanding of feline diabetes. Part 2: treatment","volume":"2","author":"Martin","year":"2000","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2012.12.002_bib24","unstructured":"Fondacaro JV, Greco DS, Crans DC. Treatment of feline diabetes mellitus with protamine zinc alanine insulin alone compared with PZI and oral vanadium salts [abstract]. In: Proceedings of the 17th ACVIM Forum. Chicago: p. 710."},{"issue":"23","key":"10.1016\/j.cvsm.2012.12.002_bib25","first-page":"1135","article-title":"Pancreatic islet beta cell protective effect of oral vanadyl sulphate in streptozotocin-induced diabetic rats, an ultrastructure study","volume":"13","author":"Ahmadi","year":"2010","journal-title":"J\u00a0Biol Sci"},{"issue":"5","key":"10.1016\/j.cvsm.2012.12.002_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.metabol.2011.10.007","article-title":"A\u00a0tea\/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity","volume":"61","author":"Clark","year":"2012","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.cvsm.2012.12.002_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1098-612X(03)00006-8","article-title":"Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet","volume":"5","author":"Mazzaferro","year":"2003","journal-title":"J\u00a0Feline Med Surg"},{"issue":"3","key":"10.1016\/j.cvsm.2012.12.002_bib28","first-page":"726","article-title":"Switching to an ultra-low carbohydrate diet has a similar effect on postprandial blood glucose concentrations to administering acarbose to healthy cats fed a high carbohydrate diet","volume":"20","author":"Singh","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2012.12.002_bib29","series-title":"BSAVA manual of canine and feline endocrinology","first-page":"133","article-title":"Feline diabetes mellitus","author":"Rand","year":"2012"},{"issue":"1","key":"10.1016\/j.cvsm.2012.12.002_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6823-3-3","article-title":"Glucagon-like peptide 1 improved glycemic control in type 1 diabetes","volume":"3","author":"Behme","year":"2003","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"10.1016\/j.cvsm.2012.12.002_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1089\/dia.2011.0204","article-title":"Dipeptidyl peptidase-4 inhibitors: 3 years of experience","volume":"14","author":"Derosa","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.cvsm.2012.12.002_bib32","first-page":"1505","article-title":"Comparison of the GLP-1 analogues exenatide (short-acting), exenatide (long-acting) and the DPP-4 inhibitor Sitagliptin to increase insulin secretion in healthy cats [abstract]","volume":"26","author":"Padrutt","year":"2012","journal-title":"J Vet Intern Med"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561612002124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561612002124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T20:29:08Z","timestamp":1715113748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561612002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0195561612002124"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2012.12.002","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}